Article Details

AstraZeneca's (AZN) Imfinzi+Imjudo Gets Japan Nod for 2 Cancers - Zacks

Retrieved on: 2022-12-29 14:19:50

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's (AZN) Imfinzi+Imjudo Gets Japan Nod for 2 Cancers - Zacks. View article details on hiswai:

Excerpt

The Japanese Ministry of Health approves AstraZeneca's (AZN) Imfinzi plus Imjudo for treating advanced liver cancer and lung cancer.

Article found on: www.zacks.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up